Otonomy
(NASDAQ:OTIC)
$0.1794
-0.0496[-21.66%]
At close: Nov 30(Delayed 15-Minutes)
Get Real Time Here
$0.2205
0.0411[22.91%]
After Hours: 7:59PM EDT
Day Range0.17 - 0.3352 Wk Range0.07 - 2.59Open / Close0.27 / 0.18Float / Outstanding43.1M / 57.2M
Vol / Avg.195.1M / 10.3MMkt Cap10.3MP/E-50d Avg. Price0.16
Div / Yield-Payout Ratio-Total Float43.1MEPS-0.18

Otonomy Stock (NASDAQ:OTIC), Quotes and News Summary

Otonomy Stock (NASDAQ: OTIC) stock price, news, charts, stock research, profile.

Loading...
Day Range0.17 - 0.3352 Wk Range0.07 - 2.59Open / Close0.27 / 0.18Float / Outstanding43.1M / 57.2M
Vol / Avg.195.1M / 10.3MMkt Cap10.3MP/E-50d Avg. Price0.16
Div / Yield-Payout Ratio-Total Float43.1MEPS-0.18
Globe Newswire - Jan 6, 2022, 7:51AM
InvestorsObserver - Nov 18, 2022, 10:12AM
InvestorsObserver - Nov 14, 2022, 10:57AM
Seeking Alpha - Nov 10, 2022, 5:05PM
InvestorsObserver - Oct 14, 2022, 12:08PM
InvestorsObserver - Aug 2, 2022, 2:02PM
Seeking Alpha - May 9, 2022, 4:34PM
InvestorsObserver - Apr 27, 2022, 2:15PM
Seeking Alpha - Apr 4, 2022, 12:23PM
InvestorsObserver - Jan 18, 2022, 6:50AM
Sector: Health Care.Industry: Pharmaceuticals
Otonomy Inc is a biopharmaceutical company, focuses on the development and commercialization of therapeutics for diseases and disorders of the ear. It offers OTIPRIO, a ciprofloxacin otic suspension for use during tympanostomy tube placement surgery in pediatric patients. The company also develops OTO-104, a sustained-exposure formulation of the steroid dexamethasone for the treatment of Meniere's disease and other inner ear conditions; and OTO-311, a sustained-exposure formulation for the treatment of tinnitus. All the business activity primarily operates through the region of the United States.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-02-27
REV
Q3 2022Est.ActualSurprise
EPS-0.190-0.180 0.0100
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Otonomy (OTIC) stock?

A

You can purchase shares of Otonomy (NASDAQ: OTIC) through any online brokerage.

View our list of the best stock brokerages.

Q

What is the target price for Otonomy (OTIC) stock?

A

The latest price target for Otonomy (NASDAQ: OTIC) was reported by Piper Sandler on Thursday, October 13, 2022. The analyst firm set a price target for 0.50 expecting OTIC to rise to within 12 months (a possible 178.71% upside). 3 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Otonomy (OTIC)?

A

The stock price for Otonomy (NASDAQ: OTIC) is $0.1794 last updated November 30, 2022, 9:00 PM UTC.

Q

Does Otonomy (OTIC) pay a dividend?

A

There are no upcoming dividends for Otonomy.

Q

When is Otonomy (NASDAQ:OTIC) reporting earnings?

A

Otonomy’s Q4 earnings are confirmed for Monday, February 27, 2023.

Q

Is Otonomy (OTIC) going to split?

A

There is no upcoming split for Otonomy.

Q

What sector and industry does Otonomy (OTIC) operate in?

A

Otonomy is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.